🌐 Durvalumab

organization

Durvalumab is an immunotherapy organization involved in the development and commercialization of cancer treatments, monitored globally for its contributions to innovative medical therapies.

2
Signals
2
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
‘We live with a big burden’: US sexual abuse survivor hopes priest’s death brings closure active Health responder 100%
Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows expired Health involved 100%